Clal Biotechnology Industries Ltd (CBI) — Financial Flexibility Index
Clal Biotechnology Industries Ltd (CBI) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of ILA-1.06 Million (operating CF ILA-1.06 Million minus capex ILA0.00) represents 0% of total liabilities (ILA19.52 Million). Check Clal Biotechnology Industries Ltd (CBI) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clal Biotechnology Industries Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Clal Biotechnology Industries Ltd across 19 annual periods. For the full cash flow conversion analysis, see Clal Biotechnology Industries Ltd cash flow conversion.
Annual Financial Flexibility Index for Clal Biotechnology Industries Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Clal Biotechnology Industries Ltd. Explore debt repayment capacity of Clal Biotechnology Industries Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA-6.48 Million | ILA21.52 Million | ▼ -30.8% |
| 2023 | -0.23x | ILA-8.51 Million | ILA-8.51 Million | ILA36.98 Million | ▲ +84.9% |
| 2022 | -1.53x | ILA-57.76 Million | ILA-59.04 Million | ILA37.79 Million | ▼ -309.9% |
| 2021 | -0.37x | ILA-39.73 Million | ILA-41.33 Million | ILA106.55 Million | ▼ -24.4% |
| 2020 | -0.30x | ILA-30.04 Million | ILA-33.23 Million | ILA100.24 Million | ▼ -219.6% |
| 2019 | 0.25x | ILA29.86 Million | ILA27.03 Million | ILA119.12 Million | ▲ +144.3% |
| 2018 | -0.57x | ILA-84.03 Million | ILA-86.98 Million | ILA148.46 Million | ▼ -47.6% |
| 2017 | -0.38x | ILA-86.72 Million | ILA-91.41 Million | ILA226.14 Million | ▼ -30.5% |
| 2016 | -0.29x | ILA-107.65 Million | ILA-112.63 Million | ILA366.21 Million | ▲ +4.8% |
| 2015 | -0.31x | ILA-135.94 Million | ILA-147.00 Million | ILA440.31 Million | ▼ -15.9% |
| 2014 | -0.27x | ILA-114.14 Million | ILA-115.95 Million | ILA428.44 Million | ▲ +2.2% |
| 2013 | -0.27x | ILA-147.25 Million | ILA-148.98 Million | ILA540.45 Million | ▼ -21.8% |
| 2012 | -0.22x | ILA-79.22 Million | ILA-81.22 Million | ILA354.19 Million | ▲ +68.8% |
| 2011 | -0.72x | ILA-101.82 Million | ILA-102.45 Million | ILA142.01 Million | ▲ +7.4% |
| 2010 | -0.77x | ILA-107.00 Million | ILA-111.93 Million | ILA138.20 Million | ▼ -54.0% |
| 2009 | -0.50x | ILA-77.13 Million | ILA-86.86 Million | ILA153.41 Million | ▼ -49.3% |
| 2008 | -0.34x | ILA-50.99 Million | ILA-52.41 Million | ILA151.47 Million | ▲ +17.8% |
| 2007 | -0.41x | ILA-45.45 Million | ILA-47.05 Million | ILA110.98 Million | ▲ +77.4% |
| 2006 | -1.81x | ILA-22.67 Million | ILA-23.55 Million | ILA12.50 Million | — |